Home Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children
Article
Licensed
Unlicensed Requires Authentication

Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children

  • Joanna Gajewska EMAIL logo , Witold Klemarczyk , Jadwiga Ambroszkiewicz , Katarzyna Szamotulska , Magdalena Chełchowska and Halina Weker
Published/Copyright: February 18, 2015
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 28 Issue 5-6

Abstract

Objective: To assess the relationships between components of the growth hormone axis, body composition, and bone markers in obese children.

Methods: We determined the levels of bone alkaline phosphatase (BALP), C-terminal telopeptide of type I collagen (CTX-I), insulin-like growth factor-I (IGF-I), and IGF-binding proteins (IGFBPs) by immunoenzymatic methods, and body composition by dual-energy X-ray absorptiometry in 45 obese and 20 non-obese children.

Results: IGF-I and functional IGFBP-3 levels, IGF-I/total IGFBP-3, and functional IGFBP-3/total IGFBP-3 molar ratios were significantly higher in obese patients than in controls. Multivariate regression analysis in obese patients showed significant associations of BALP with IGF-I (p=0.047) and percent of body fat mass (p=0.002).

Conclusion: The relationship of IGF-I and functional IGFBP-3 to BALP may support the concept of IGF-I influence on accelerated bone formation process in obesity. Moreover, IGF-I and percentage of body fat mass may be significant predictors of BALP in obese during the prepubertal period.

Keywords: bone alkaline phosphatase; collagen type I cross-linked C-telopeptide; functional IGF-binding protein-3; IGF-binding protein-1; total IGF-binding protein-3
Corresponding author: Joanna Gajewska, Screening Department, Institute of Mother and Child, Warsaw, Poland, Phone: +48-22-3277260, Fax: +48-22-3277161, E-mail:

Acknowledgments

The authors thank the staff of the Department of Internal Medicine, Endocrinology and Diabetology at the Central Clinical Hospital MSW in Warsaw for DXA measurements.

References

1. Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin North Am 2012;41:283–95.10.1016/j.ecl.2012.04.011Search in Google Scholar

2. Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metabol 2003;14:176–81.10.1016/S1043-2760(03)00049-3Search in Google Scholar

3. Buscher A, Buscher R, Pridzun L, Langkamp M, Wachendorfer N, et al. Functional and total IGFBP-3 for the assessment of disorders of the GH/IGF-I axis in children with chronic kidney disease, growth hormone deficiency, or short stature after SGA status at birth. Eur J Endocrinol 2012;166:923–31.10.1530/EJE-11-0923Search in Google Scholar PubMed

4. Baricević I, Malenković V, Jones DR, Nedić O. The influence of laparoscopic and open surgery on the concentration and structural modifications of insulin-like growth factor binding protein 3 in the human circulation. Acta Physiol Hung 2006;93:361–9.10.1556/APhysiol.93.2006.4.12Search in Google Scholar PubMed

5. Govoni KE. Insulin-like growth factor-I molecular pathways in osteoblasts: potential targets for pharmacological manipulation. Curr Molecular Pharmacology 2012;5:143–52.10.2174/1874467211205020143Search in Google Scholar

6. Munoz-Torres M, Mezquita-Raya P, Lopez-Rodrigeuez F, Torres-Vela E, de Dios Luna J, et al. The contribution of IGF-I to skeletal integrity in postmenopausal women. Clin Endocrinol 2001;55:759–66.10.1046/j.1365-2265.2001.01390.xSearch in Google Scholar PubMed

7. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, et al. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 2002;70:22–9.10.1007/s002230020048Search in Google Scholar PubMed

8. Breen ME, Laing EM, Hall DB, Hausman DB, Taylor RG, et al. 25-Hydroxyvitamin D, insulin-like growth factor-I and bone mineral accrual during growth. J Clin Endocrinol Metab 2011;96:E89–E98.10.1210/jc.2010-0595Search in Google Scholar PubMed PubMed Central

9. Leger J, Mercat I, Alberti C, Chevenne D, Armoogum P, et al. The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children. Eur J Endocrinol 2007;157:685–92.10.1530/EJE-07-0402Search in Google Scholar PubMed

10. Rauchenzauner M, Schmidt A, Heinz-Erian P, Kapelari K, Falkensammer G, et al. Sex- and age-specific reference curve for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 2007;92:443–9.10.1210/jc.2006-1706Search in Google Scholar PubMed

11. Alberti C, Chevenne D, Mercat I, Josserand E, Armoogum-Boizeau P, et al. Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clin Chem 2011;57:1424–35.10.1373/clinchem.2011.169466Search in Google Scholar

12. Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006;39:561–8.10.1016/j.clinbiochem.2005.11.015Search in Google Scholar

13. Allemand D, Schmidt S, Rousson V, Brabant G, Gasser T, et al. Associations between body mass, leptin, IGF-I and circulating adrenal androgens with obesity and premature adrenarche. Eur J Endocrinol 2002;146:537–43.10.1530/eje.0.1460537Search in Google Scholar

14. Woelfle JF, Harz K, Roth C. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children. Exp Clin Endocrinol Diabetes 2007;115:17–23.10.1055/s-2006-957350Search in Google Scholar

15. Reinehr T, Panteliadou A, de Sousa G, Andler W. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and growth in obese children before and after reduction of overweight. J Pediatr Endocrinol Metab 2009;22:225–33.10.1515/JPEM.2009.22.3.225Search in Google Scholar

16. Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N. Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxf) 1998;48:487–92.10.1046/j.1365-2265.1998.00476.xSearch in Google Scholar

17. Ballerini MG, Ropelato MG, Domene HM, Pennisi P, Heinrich JJ, et al. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF) -IGF binding proteins axis. J Pediatr Endocrinol Metab 2004;17:749–57.10.1515/JPEM.2004.17.5.749Search in Google Scholar

18. Street ME, Smerieri A, Montanini L, Predieri B, Iughetti L, et al. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects. J Biol Regular Homeo Agents 2013;27:259–66.Search in Google Scholar

19. Vandewalle S, Taes Y, Van Helvoirt M, Debode P, Herregods N, et al. Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab 2013;98:3019–28.10.1210/jc.2012-3914Search in Google Scholar

20. Bini V, Baroncelli GI, Papi F, Celi F, Saggese G, et al. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children. Horm Res 2004;61:170–5.10.1159/000076134Search in Google Scholar

21. Weker H. Simply obesity in children. A study on the role of nutritional factors. Med Wieku Rozwoj 2006;10:3–191.Search in Google Scholar

22. Palczewska I, Niedzwiedzka Z. Somatic development indices in children and youth of Warsaw. Med Wieku Rozwoj 2001;5:18–118.Search in Google Scholar

23. Dzieniszewski J, Szponar L, Szczygieł B, Socha J, editors. Scientific foundations of nutrition in hospitals in Poland. Warsaw: National Food and Nutrition Institute, 2001.Search in Google Scholar

24. Radetti G, Bozzola M, Pasquino B, Paganini C, Aglialoro A, et al. Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children. Metabolism 1998;47:1490–3.10.1016/S0026-0495(98)90075-0Search in Google Scholar

25. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, et al. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 2005;14:48–52.10.1158/1055-9965.48.14.1Search in Google Scholar

26. Mohanraj L, Kim HS, Li W, Cai Q, Kim KE, et al. IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis. PLoS ONE 2013;8:e55084.10.1371/journal.pone.0055084Search in Google Scholar PubMed PubMed Central

27. Bang P, Brismar K, Rosenfield RG. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab 1994;78:119–27.Search in Google Scholar

28. Gajewska J, Weker H, Ambroszkiewicz J, Szamotulska K, Chełchowska M, et al. Alterations in markers of bone metabolism and adipokines following a 3-month lifestyle intervention induced weight loss in obese prepubertal children. Exp Clin Endocrinol Diabetes 2013;121:498–504.10.1055/s-0033-1347198Search in Google Scholar PubMed

29. Guevara-Aguirre J, Rosenbloom AL, Guevara-Aguirre M, Saavedra J, Procel P. Recommended IGF-I dosage causes greater fat accumulation and osseous maturation than lower dosage and may compromise long-term growth effects. J Clin Endocrinol Metab 2013;98:839–45.10.1210/jc.2012-3704Search in Google Scholar PubMed

30. Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signaling resulting in reduced bone mass. Bone 2011;48:189–96.10.1016/j.bone.2010.09.034Search in Google Scholar PubMed

31. Garnett SP, Högler W, Blades B, Baur LA, Peat J, et al. Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 2004;80:966–72.10.1093/ajcn/80.4.966Search in Google Scholar PubMed

32. Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int 1996;59:492–5.10.1007/s002239900163Search in Google Scholar

33. Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H. Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 2006;17:495–500.10.1007/s00198-005-0013-xSearch in Google Scholar PubMed

34. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, et al. Serum leptin levels is regulator of bone mass. PNAS USA 2004;101:3258–63.10.1073/pnas.0308744101Search in Google Scholar PubMed PubMed Central

35. Marcovecchio ML, Chiarelli E. Obesity and growth during childhood and puberty. World Rev Nutr Diet 2013;106: 135–41.10.1159/000342545Search in Google Scholar PubMed

36. Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, et al. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 2002;87:1593–99.10.1210/jcem.87.4.8426Search in Google Scholar PubMed

Received: 2014-7-31
Accepted: 2014-12-17
Published Online: 2015-2-18
Published in Print: 2015-5-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Obesity
  3. Childhood obesity at the crossroads
  4. Obesogenic environments: environmental approaches to obesity prevention
  5. Childhood obesity and eating behaviour
  6. Hypothalamic obesity in children: pathophysiology to clinical management
  7. The reliability of body mass index in the diagnosis of obesity and metabolic risk in children
  8. Determining abdominal obesity cut-offs and relevant risk factors for anthropometric indices in Turkish children and adolescents
  9. The effect of body mass index on blood pressure varies by race among obese children
  10. Insulin secretion response during oral glucose tolerance test is related to low cardiorespiratory fitness in obese adolescents
  11. Is there a relationship between cardiovascular risk factors and dehydroepiandrosterone sulfate levels in childhood obesity?
  12. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children
  13. Childhood obesity, thyroid function, and insulin resistance – is there a link? A longitudinal study
  14. Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children
  15. Osteocalcin is inversely associated with adiposity and leptin in adolescent boys
  16. Association between cardiovascular risk factors and carotid intima-media thickness in prepubertal Brazilian children
  17. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach
  18. The role of apolipoprotein E polymorphism in improving dyslipidemia in obese adolescents following physical exercise and National Cholesterol Education Program Step II intervention
  19. Review article
  20. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome?
  21. Original articles
  22. IGF-II expression and methylation in small for gestational age infants
  23. Early screening of FTO and MC4R variants in newborns of Greek origin
  24. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency
  25. The prevalence of vitamin D deficiency among schoolchildren: a cohort study from Xinxiang, China
  26. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?
  27. Vitamin D status and its associations with components of metabolic syndrome in healthy children
  28. Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome
  29. Patient reports
  30. Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene
  31. Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy
  32. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening
  33. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD)
  34. Ovotesticular disorder of sex development with unusual karyotype: patient report
  35. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China
  36. Virilizing adrenal oncocytoma in a 9-year-old girl: rare neoplasm with an intriguing postoperative course
  37. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency
  38. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation
  39. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia
  40. Hyperthyroidism hidden by congenital central hypoventilation syndrome
  41. The use of pamidronate for acute vitamin D intoxication, clinical experience with three cases
  42. Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
  43. Cushing syndrome related to leukemic infiltration of the central nervous system
  44. Hashimoto’s encephalopathy: a rare pediatric brain disease
  45. Short communication
  46. A novel ABCD1 gene mutation in a Chinese patient with X-linked adrenoleukodystrophy
https://doi.org/10.1515/jpem-2014-0326
Keywords for this article
bone alkaline phosphatase; collagen type I cross-linked C-telopeptide; functional IGF-binding protein-3; IGF-binding protein-1; total IGF-binding protein-3

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Obesity
  3. Childhood obesity at the crossroads
  4. Obesogenic environments: environmental approaches to obesity prevention
  5. Childhood obesity and eating behaviour
  6. Hypothalamic obesity in children: pathophysiology to clinical management
  7. The reliability of body mass index in the diagnosis of obesity and metabolic risk in children
  8. Determining abdominal obesity cut-offs and relevant risk factors for anthropometric indices in Turkish children and adolescents
  9. The effect of body mass index on blood pressure varies by race among obese children
  10. Insulin secretion response during oral glucose tolerance test is related to low cardiorespiratory fitness in obese adolescents
  11. Is there a relationship between cardiovascular risk factors and dehydroepiandrosterone sulfate levels in childhood obesity?
  12. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children
  13. Childhood obesity, thyroid function, and insulin resistance – is there a link? A longitudinal study
  14. Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children
  15. Osteocalcin is inversely associated with adiposity and leptin in adolescent boys
  16. Association between cardiovascular risk factors and carotid intima-media thickness in prepubertal Brazilian children
  17. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach
  18. The role of apolipoprotein E polymorphism in improving dyslipidemia in obese adolescents following physical exercise and National Cholesterol Education Program Step II intervention
  19. Review article
  20. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome?
  21. Original articles
  22. IGF-II expression and methylation in small for gestational age infants
  23. Early screening of FTO and MC4R variants in newborns of Greek origin
  24. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency
  25. The prevalence of vitamin D deficiency among schoolchildren: a cohort study from Xinxiang, China
  26. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?
  27. Vitamin D status and its associations with components of metabolic syndrome in healthy children
  28. Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome
  29. Patient reports
  30. Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene
  31. Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy
  32. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening
  33. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD)
  34. Ovotesticular disorder of sex development with unusual karyotype: patient report
  35. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China
  36. Virilizing adrenal oncocytoma in a 9-year-old girl: rare neoplasm with an intriguing postoperative course
  37. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency
  38. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation
  39. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia
  40. Hyperthyroidism hidden by congenital central hypoventilation syndrome
  41. The use of pamidronate for acute vitamin D intoxication, clinical experience with three cases
  42. Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
  43. Cushing syndrome related to leukemic infiltration of the central nervous system
  44. Hashimoto’s encephalopathy: a rare pediatric brain disease
  45. Short communication
  46. A novel ABCD1 gene mutation in a Chinese patient with X-linked adrenoleukodystrophy
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0326/html
Scroll to top button